RecruitingDepression, PostpartumPostpartum Depression (PPD)Post-partum Depression

Brexanolone Lifting Outcomes Of Moms

Eligible age

15–45 yrs

Accepts

Women

Locations

13 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this research study is to test the study drug, LPCN 1154A, as a possible treatment for postpartum depression (PPD). The trial aims to determine: * If LPCN 1154A reduces depressive symptoms in subjects with severe PPD * How well LPCN 1154A is tolerated and what side effects it may cause

Sponsor: Lipocine Inc.